Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQspaediatric-dermatology

Paeds SAQs · paediatric-dermatology

Tinea and fungal skin infection — formative SAQs

Two formative SAQs on tinea and fungal skin infection in children: a five-year-old with a scaly bald scalp patch and broken hair stubs testing the recognition of tinea capitis, the species-guided oral therapy, and household carrier screening; and a four-year-old with a painful boggy purulent scalp mass after contact with a new kitten testing the recognition and management of kerion without incision, alongside a question on tinea incognito from a steroid-containing cream.

20 marks30 min
On this page & tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
Tinea and fungal skin infection

SAQ 1 — The scaly bald scalp patch (10 marks, 15 minutes)

A five-year-old boy presents with a three-week history of an itchy, scaly, gradually enlarging bald patch on his scalp. On examination there is a four-centimetre patch of hair loss with broken hair stubs and black dots flush with the skin, mild scaling, and a firm enlarged occipital lymph node. Potassium hydroxide microscopy of a plucked hair shows branching septate hyphae and arthroconidia. [1]

a) What is the diagnosis, and which two clinical features distinguish it from alopecia areata? (2 marks) [1]

b) State the definitive treatment principle for this condition and explain why a topical antifungal cream alone cannot work. (2 marks) [2]

c) Fungal culture returns Trichophyton tonsurans. Name the preferred oral antifungal for this species and give the weight-banded daily dose for a 22 kg child, with the duration. Justify the species-specific choice using the evidence. (4 marks) [4] [5]

d) Outline the household and public-health measures that prevent recurrence after treatment. (2 marks) [10]


SAQ 2 — The painful boggy scalp mass and the steroid cream (10 marks, 15 minutes)

A four-year-old girl is brought to the emergency department with a two-day history of a painful, swollen, boggy, purulent mass on the scalp, studded with pustules, with crusting and enlarged cervical nodes. The family acquired a kitten two weeks earlier. In the next cubicle, a parent asks whether to keep using a combined corticosteroid, antifungal and antibiotic cream on an itchy annular forearm rash. [1]

a) What is the scalp diagnosis, and why is the new kitten a relevant clue? (2 marks) [1]

b) Outline the definitive management of this scalp lesion, naming the drug classes and the specific procedure that must be avoided, with the reason. (4 marks) [2]

c) Explain to the parent what will happen if the combined cream is continued on the annular forearm rash, and name the resulting condition. (2 marks) [6]

d) State two sequelae of inadequate treatment of the scalp lesion that you would discuss with the family. (2 marks) [1]

References

  1. [1]Gupta AK, Polla Ravi S, Wang T, et al. An update on tinea capitis in children. Pediatr Dermatol, 2024.PMID 39113245
  2. [2]Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol, 2014.PMID 25234064
  3. [4]Tey HL, Tan AS, Chan YC Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol, 2011.PMID 21334096
  4. [5]Gupta AK, Drummond-Main C Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. Pediatr Dermatol, 2013.PMID 22994156
  5. [6]Leung AK, Lam JM, Leong KF, et al. Tinea corporis: an updated review. Drugs Context, 2020.PMID 32742295
  6. [10]Dessinioti C, Papadogeorgaki E, Athanasopoulou V, et al. Screening for asymptomatic scalp carriage in household contacts of patients with tinea capitis during 1997-2011: a retrospective hospital-based study. Mycoses, 2014.PMID 24372570